Public annual accounts

DEKAMED financials

Name: DEKAMED financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DEKAMED, with comparable measures and links to available source documents.

Company overview

Registry number

0669787077

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for DEKAMED

2025 versus 2024

Operating line: €46,052
EBITDA: €45,525
Total assets: €113,533
Equity: €85,667

EBITDA margin +98.9% · Equity ratio +75.5%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€46,052	€45,525	€113,533	€85,667	-
202431 Dec 2024	€68,576	€67,942	€190,511	€108,924	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report